EVOLENT HEALTH INC's ticker is EVH and the CUSIP is 30050B101. A total of 121 filers reported holding EVOLENT HEALTH INC in Q4 2016. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $2,385,000 | -35.5% | 300,053 | +2.1% | 0.01% | -40.0% |
Q1 2019 | $3,695,000 | -33.1% | 293,757 | +6.2% | 0.01% | -37.5% |
Q4 2018 | $5,521,000 | -25.5% | 276,730 | +6.1% | 0.02% | -15.8% |
Q3 2018 | $7,407,000 | +27.2% | 260,825 | -5.7% | 0.02% | +26.7% |
Q2 2018 | $5,824,000 | +14.2% | 276,675 | -22.7% | 0.02% | +7.1% |
Q1 2018 | $5,099,000 | -33.1% | 357,815 | -42.3% | 0.01% | -33.3% |
Q4 2017 | $7,626,000 | +0.9% | 620,040 | +46.0% | 0.02% | -4.5% |
Q3 2017 | $7,557,000 | -7.1% | 424,550 | +32.3% | 0.02% | -12.0% |
Q2 2017 | $8,133,000 | +2.9% | 320,840 | -9.5% | 0.02% | 0.0% |
Q1 2017 | $7,904,000 | +48.7% | 354,440 | -1.3% | 0.02% | +38.9% |
Q4 2016 | $5,315,000 | +9.6% | 359,090 | +82.3% | 0.02% | +12.5% |
Q3 2016 | $4,850,000 | +91.9% | 196,990 | +49.6% | 0.02% | +77.8% |
Q2 2016 | $2,527,000 | +87.3% | 131,640 | +3.1% | 0.01% | +80.0% |
Q1 2016 | $1,349,000 | +37.2% | 127,740 | +57.4% | 0.01% | +25.0% |
Q4 2015 | $983,000 | +28.3% | 81,180 | +69.1% | 0.00% | +33.3% |
Q3 2015 | $766,000 | -17.1% | 48,010 | +1.3% | 0.00% | 0.0% |
Q2 2015 | $924,000 | – | 47,410 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Voce Capital Management LLC | 323,694 | $9,807,928 | 16.97% |
Engaged Capital LLC | 1,747,252 | $52,941,736 | 7.66% |
Greenhouse Funds LLLP | 1,399,260 | $42,397,578 | 3.31% |
Rock Point Advisors, LLC | 330,448 | $10,012,574 | 3.29% |
FORMULA GROWTH LTD | 299,510 | $9,075,153 | 2.89% |
Rock Springs Capital Management LP | 3,803,500 | $115,246,050 | 2.74% |
Granahan Investment Management | 2,914,350 | $88,304,805 | 2.72% |
SECTORAL ASSET MANAGEMENT INC | 488,142 | $14,790,703 | 2.47% |
Summit Creek Advisors LLC | 557,070 | $16,879,221 | 2.11% |
Orbimed Advisors | 2,895,632 | $87,737,650 | 1.59% |